Please assess the completion status of the following clinical trial:

Trial Title: Thumb-ECG Ambulant Screening for Atrial Fibrillation in Patients Treated for Hyperthyroidism (TAMBOURINE)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patient is deemed suitable for treatment with radioiodine or antithyroid drugs~* Patient has a thyreotropin (TSH) value below 0,1 mIU/L, measured less than 2 weeks before inclusion~* Patient has a CHADS-VASc-score of 1 point or higher (excluding if 1 point is for female sex only)~* Patient gives written consent to participate in study~Exclusion Criteria:~* Patient has a previously known diagnosis of atrial fibrillation

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Hyperthyroid patients (Type: None): Patients with hyperthyroidism admitted for treatment with radioiodine or antithyroid drugs

Based on this trial design, predict the completion outcome and termination type (if applicable).